Breast Cancer & Genes: Assessing Risk
Study Questions Accuracy of Genetic Risk Models Used to Determine Testing
June 19, 2007 -- Many breast cancer patients who have a genetic predisposition for the disease, but who do not have an obvious family link to breast cancer, are not considered candidates for genetic testing, new research shows.
The study challenges the accuracy of models used to determine who should be offered testing for the breast cancer gene mutation BRCA, finding the models to be poor predictors of risk for women with few female relatives over the age of 45.
The models assess risk based on known family history of breast cancer.
"You have to have a family to have a family history," researcher Jeffrey Weitzel, MD, of the City of Hope Cancer Center in Duarte, Calif., tells WebMD.
He added that women with few older female relatives on either their mother's or father's sides were not well served by the available models.
Inherited gene mutations play a role in about 5% of all breast cancers. But women with BRCA1 or BRCA2 mutations have about a 50% to 85% lifetime risk of developing the disease, compared with a roughly 10% lifetime risk among the general population of women.
BRCAcarriers are also much more likely to develop breast cancers before the age of 50, and their risk for ovarian cancer is also greatly increased.
Identifying women with BRCA mutations is a proven strategy for reducing the risk of death from breast or ovarian cancer. But since the mutations are rare, testing all women or even testing all breast cancer patients may not be practical.
Most women who develop breast cancer before the age of 40 are considered for genetic testing, but clinicians often rely on the prediction models to determine whether women diagnosed in their 40s should be screened if they have no known family link to the disease.
Weitzel and colleagues assessed the accuracy of the prediction models in their study appearing in the June 20 issue of TheJournal of the American Medical Association.
A total of 1,543 breast cancer patients enrolled in a cancer registry between 1997 and 2007 were included in the study. Of these patients, 306 were diagnosed before age 50 and reported no known first- or second-degree relatives with breast or ovarian cancers.